info icon

This is a non-core endpoint: only basic statistics are computed.

Use of levodopa decarbox-comt-inhibitor

PDMED_LEVODOPA_DECARBOX_COMTINHIBITOR

No definition available.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC N04BA03

1 out of 7 registries used, show all original rules.

746

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

746

diagram downward connector

Include endpoints None

746

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

732

diagram downward connector
PDMED_LEVODOPA_DECARBOX_COMTINHIBITOR

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 732 268 464
Unadjusted prevalence (%) 0.19 0.13 0.28
Mean age at first event (years) 68.35 67.26 68.97

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

↥

Index endpoint: PDMED_LEVODOPA_DECARBOX_COMTINHIBITOR – Use of levodopa decarbox-comt-inhibitor
GWS hits:

Survival analyses between endpoints

↥

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Use of levodopa decarbox-comt-inhibitor

↥

Endpoint not on priority list, no data to show.